ALTIMMUNE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
ALTIMMUNE, INC. (ALT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $413.62 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2018-04-02
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $413.62K, a 85.23% decline from fiscal 2016.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $2.80M, a 833.33% increase from fiscal 2015.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2015 was $300.00K, a 50.00% increase from fiscal 2014.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2014 was $200.00K, a 100.00% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|
| 2017-12-31 | $413.62K 10-K · filed 2018-04-02 | |
| 2016-12-31 | $2.80M 10-K · filed 2017-03-14 | |
| 2015-12-31 | $300.00K 10-K · filed 2017-03-14 | |
| 2014-12-31 | $200.00K 10-K · filed 2017-03-14 | |
| 2013-12-31 | $100.00K 10-K · filed 2016-03-11 | $28.00K 10-K · filed 2014-03-11 |
| 2012-12-31 | $10.00K 10-K · filed 2015-03-11 | $9.07K 10-K · filed 2013-03-14 |
| 2011-12-31 | $35.00K 10-K · filed 2014-03-11 | $34.94K 10-K · filed 2013-03-14 |
| 2010-12-31 | $29.32K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |